tradingkey.logo
tradingkey.logo
검색

Neogenomics Inc

NEO
관심 목록에 추가
14.970USD
+0.380+2.60%
종가 07/01, 16:00ET시세는 15분 지연됩니다
1.95B시가총액
손실P/E TTM

자세한 내용은 Neogenomics Inc 회사

NeoGenomics, Inc. is a cancer diagnostics company specializing in cancer genetics testing and information services. The Company offers comprehensive oncology-focused testing menus across the cancer continuum, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with diagnostic and predictive testing to help them diagnose and treat cancer. Its services include clinical cancer testing; interpretation and consultative services; molecular and NGS testing; comprehensive technical and professional services offering; clinical trials and research; validation laboratory services, and oncology data solutions. It operates a network of laboratories for full-service sample processing and analysis services throughout the United States and a full-service sample-processing laboratory in Cambridge, United Kingdom. Its testing services include Cytogenetics (karyotype analysis), Fluorescence In-Situ Hybridization (FISH), Flow cytometry, and others.

Neogenomics Inc 정보

종목 코드 NEO
회사 이름Neogenomics Inc
상장일Dec 10, 2012
CEOZook (Antony P)
직원 수2200
유형Ordinary Share
회계 연도 종료Dec 10
주소9490 Neogenomics Way
도시FORT MYERS
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호33912
전화12397680600
웹사이트https://neogenomics.com/
종목 코드 NEO
상장일Dec 10, 2012
CEOZook (Antony P)

Neogenomics Inc의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. Jeffrey Scott (Jeff) Sherman
Mr. Jeffrey Scott (Jeff) Sherman
Chief Financial Officer
Chief Financial Officer
220.01K
+0.96%
Mr. Warren Stone
Mr. Warren Stone
President, Chief Operating Officer
President, Chief Operating Officer
164.03K
+3.45%
Mr. Stephen Michael Kanovsky
Mr. Stephen Michael Kanovsky
Independent Director
Independent Director
75.42K
+30.60%
Dr. Neil Gunn
Dr. Neil Gunn
Independent Director
Independent Director
51.18K
+45.09%
Ms. Felicia Williams
Ms. Felicia Williams
Independent Director
Independent Director
30.24K
+76.32%
Ms. Marjorie C. Green
Ms. Marjorie C. Green
Independent Director
Independent Director
22.96K
--
Ms. Lynn A. Tetrault, J.D.
Ms. Lynn A. Tetrault, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Alison L. Hannah, M.D.
Dr. Alison L. Hannah, M.D.
Independent Director
Independent Director
--
--
Mr. Michael A. Kelly
Mr. Michael A. Kelly
Lead Independent Director
Lead Independent Director
--
--
Mr. David B. Perez
Mr. David B. Perez
Independent Director
Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Jeffrey Scott (Jeff) Sherman
Mr. Jeffrey Scott (Jeff) Sherman
Chief Financial Officer
Chief Financial Officer
220.01K
+0.96%
Mr. Warren Stone
Mr. Warren Stone
President, Chief Operating Officer
President, Chief Operating Officer
164.03K
+3.45%
Mr. Stephen Michael Kanovsky
Mr. Stephen Michael Kanovsky
Independent Director
Independent Director
75.42K
+30.60%
Dr. Neil Gunn
Dr. Neil Gunn
Independent Director
Independent Director
51.18K
+45.09%
Ms. Felicia Williams
Ms. Felicia Williams
Independent Director
Independent Director
30.24K
+76.32%
Ms. Marjorie C. Green
Ms. Marjorie C. Green
Independent Director
Independent Director
22.96K
--

자주 묻는 질문

Neogenomics Inc의 상위 5대 주주는 누구인가요?

Neogenomics Inc의 상위 5대 주주는 다음과 같습니다: Mr. Jeffrey Scott (Jeff) Sherman

Neogenomics Inc(NEO)의 주식을 보유한 기관은 몇 개입니까?

2026Q1 기준으로, Neogenomics Inc의 주식을 보유한 기관은 총 564곳이며, 이들이 보유한 주식의 총 가치는 약 156.61M로 전체 발행 주식의 120.32%를 차지합니다. 이는 2025Q4 대비 7515333.00 증가한 수치입니다.

Neogenomics Inc의 최대 수익원은 무엇인가요?

2026Q1 기준, Neogenomics Inc의 Clinical Services-Client direct billing 부문이 가장 높은 매출을 기록했으며, 금액은 518.84M로 전체 매출의 71.34%를 차지했습니다.